A. Chuansumrit, S. Jaovisidha, N. Sirachainan, Tachit Jiravichitchai, P. Kadegasem, Ketsuda Kempka, Monratta Pitakcharoen, Wannaphorn Rotchanpanya
{"title":"每月一次小剂量埃米珠单抗以及每月一次小剂量埃米珠单抗和因子 VIII 浓缩物预防性治疗对 A 型血友病患者的疗效:3 年随访病例系列报告","authors":"A. Chuansumrit, S. Jaovisidha, N. Sirachainan, Tachit Jiravichitchai, P. Kadegasem, Ketsuda Kempka, Monratta Pitakcharoen, Wannaphorn Rotchanpanya","doi":"10.29011/2574-7754.101872","DOIUrl":null,"url":null,"abstract":"Dose Emicizumab, and Sequential Monthly Low Dose Emicizumab and Factor VIII Concentrate Prophylaxis among Patients with Hemophilia A: A Case Series Report of 3-Year Follow-Up.","PeriodicalId":72213,"journal":{"name":"Annals of case reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of Monthly Low Dose Emicizumab, and Sequential Monthly Low Dose Emicizumab and Factor VIII Concentrate Prophylaxis among Patients with Hemophilia A: A Case Series Report of 3-Year Follow-Up\",\"authors\":\"A. Chuansumrit, S. Jaovisidha, N. Sirachainan, Tachit Jiravichitchai, P. Kadegasem, Ketsuda Kempka, Monratta Pitakcharoen, Wannaphorn Rotchanpanya\",\"doi\":\"10.29011/2574-7754.101872\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dose Emicizumab, and Sequential Monthly Low Dose Emicizumab and Factor VIII Concentrate Prophylaxis among Patients with Hemophilia A: A Case Series Report of 3-Year Follow-Up.\",\"PeriodicalId\":72213,\"journal\":{\"name\":\"Annals of case reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2574-7754.101872\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2574-7754.101872","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
血友病 A 患者中的小剂量埃米珠单抗和每月序贯小剂量埃米珠单抗及因子 VIII 浓缩物预防治疗:3 年随访病例系列报告。
Effectiveness of Monthly Low Dose Emicizumab, and Sequential Monthly Low Dose Emicizumab and Factor VIII Concentrate Prophylaxis among Patients with Hemophilia A: A Case Series Report of 3-Year Follow-Up
Dose Emicizumab, and Sequential Monthly Low Dose Emicizumab and Factor VIII Concentrate Prophylaxis among Patients with Hemophilia A: A Case Series Report of 3-Year Follow-Up.